Profile Picture
Français
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Canada
  • World
  • Entertainment
  • Sci/Tech
  • Business
  • Politics
  • Sports
  • Lifestyle
Order byBest matchMost fresh
  • Past 24 hours
    • Any time
    • Past hour
    • Past 7 days
    • Past 30 days
39m

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in ...

Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Coast guard patrol ships to be pulled from service 'sooner than expected,' amid pressures from new security mandate
Major League Soccer flipping calendar, with season to run July through May
Former immigration minister says Canada's reputation on welcoming refugees is at risk
A shaky coalition and 'near-death' election put Eby under scrutiny at NDP convention
Iran seizes tanker in Strait of Hormuz, US official says, as tensions remain high in region
Modi's coalition set for big win in a key state election, bolstering his popularity
Russian drone and missile attack on Kyiv kills 6 people and injures at least 35
Ahmed sent off, Canada holds on for scoreless draw with Ecuador in soccer friendly
Anthony Koch: How conservatives helped the left undermine the West
Chinese astronauts return from space station after delay blamed on space debris damage
Freezing rain will hit Quebec and Ontario this weekend
Fresh off commissioning new aircraft carrier, China starts sea trials of amphibious assault ship
Latest opioid settlement plan with OxyContin maker Purdue and Sackler family getting few objections
New major projects list has some Indigenous buy-in, Carney says OKs still needed
Meet Ruby the 'talking' and 'texting' dog
Celebrini shaping up to be a new face of the NHL: ‘We’re certainly getting there’
Feedback
  • Privacy
  • Terms